HY-0102 Monotherapy in Patients With Locally Advanced/Metastatic Solid Tumours

计划入组 17 人 · 首次发布于 2021 年 6 月 4 日

A Study of XY0206 in Subjects With Advanced or Metastatic Solid Tumours

计划入组 34 人 · 首次发布于 2018 年 9 月 5 日

Study of Intratumoral IVX037 in Patients With Advanced or Metastatic Solid Tumours

计划入组 70 人 · 首次发布于 2022 年 6 月 22 日

metabolic drug (advanced solid tumor)

Neo-T (advanced solid tumor)

NeoTIL-ACT

Solid Biosciences Inc.

United States

Yichang Humanwell Oral Solid Dosage Plant

China

ADVANCED BIONICS

France

FDA Grants Priority Review to Enhertu for HER2-Positive Metastatic Solid Tumors

FDA Approves Subcutaneous Opdivo Qvantig for Multiple Solid Tumors

Adcentrx Therapeutics Doses First Patient in Phase 1a/b Trial of STEAP1-Targeting ADC ADRX-0405 for Advanced Solid Tumors